| ITM Shareholders |
|
|
|
|
The ITM shareholder network consists mainly of a group of private equity investors and family offices in collaboration with key executives, employees and other stakeholders.
All current Shareholders of ITM AG are experienced experts and contributors in their respective fields of work and ITM is very fortunate that such an extraordinary and dedicated group of individuals and organisations have also entrusted significant amounts of funding (smart money) for the development of the company.
For further information please contact the ITM executive management directly at This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
News
ITG has received the Manufacturing License for Lu-177 n.c.a.As of December 2011, ITG Isotope Technologies Garching GmbH has successfully passed the audit of the GMP production of the...Read more... |
ITG Isotope Technologies Garching GmbH (Germany) announces broad collaboration with ANSTO (Australia) on radioisotopesGarching, Germany, June 3, 2011. ITG Isotope Technologies Garching GmbH (ITG), a specialist in the development and production of innovative...Read more... |
Helmholtz Zentrum München and ITM AG enter antibody dealAscenion has mediated a license agreement between the Helmholtz Zentrum München and ITM Isotopen Technologien München AG providing the company...Read more... |


